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 Solubility is prerequisite for drug absorption across absorptive cell lining the 
small intestine. It is a problem for poor water soluble drug because limiting 
its bioavailability when administered by oral route. Lipid based delivery 
system such as self-nanoemulsifying delivery system (SNEDDS) can be utilized 
in improving its solubility so that better bioavailability is achieved. 
Pterostilbene has extremely low solubility in water then become its limiting 
factor for the bioavailability. This research developed SNEDDS for oral 
delivery of pterostilbene. Optimum composition of SNEDDS formulation was 
judged by its dispersion efficiency and clarity when dispersed in water. The 
efficiency of this formula in enhancing bioavailability was assessed by in vitro 
digestion model to predict its bioavailability by determining its 
bioaccessibility. The result showed that optimum composition of SNEDDS 
was achieved by soybean oil-Croduret® 50-Span 80-PEG 400 in ratio of 16.37 %, 
32.07 %, 11.56 %, and 40 %, respectively. This formula has bioacessibility of 
91.48 ± 2.18 %, and it is much higher compared to pterostilbene that was not  
formulated into SNEDDS, i.e 4.63 ± 1.11 %. Determined by dynamic light  
scattering, this optimum formula has droplet size of 31.8 nm when dispersed 
in water.  
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1. Introductions 
Drug can’t exert its beneficial effect unless it is 
absorbed and bioavailable at an appropriate 
concentration. Those are influenced by many factors 
amongst them are drug solubility properties, drug 
delivery design, and its administration route. Concerning 
to solubility, molecular dispersion in gastrointestinal 
liquid is prerequisite for drug absorption (Dahan and 
Hoffman, 2008). Therefore a lipophilic drug will be a 
problem when formulated for oral route delivery 
because its solubility property will limit its bioavailability 
(Amidon et al., 1995). Hydrophilic layer of unstirred 
water layer (UWL) which is lined above absorptive cell is 
primary limitation for poor water drug soluble for its 
absorption and bioavailability (Dahan and Hoffman, 
2008). Pterostilbene is promising for its activities as anti-
inflammation (Choo et al., 2014), anti-hiperglycemic 
(Manickam et al., 1997), and anti-aterosclerosis (Park et 
al., 2010). Unfortunately, pterostilbene is poorly water 
soluble, approximately 21 μg/mL (Bethune et al., 2011). 
Then it needs formulation strategy in improving its 
solubility to ensure its efficacy (Yeo et al., 2013). 
One of drug delivery system that can be utilized 
in improving solubility and bioavailability of lipophilic 
drug  is self-nanoemulsifying drug delivery systems 
(SNEDDS) (Neslihan Gursoy and Benita, 2004). SNEDDS 
is isotropic mixture of lipid phase, surfactant, and co -
surfactant. Its lipid phase is not only able in presenting 
lipophilic drug in molecular dispersion prior to 
absorption but also improving bioaccessibility of 
lipophilic drug by stimulating the enzymatic digestion of 
the lipid phase in small intestine (Ahmed et al., 2012; 
Pouton, 2000), thus improving its bioavailability (Porter 
et al., 2008; Rao et al., 2013). The efficiency of such 
mechanisms are strongly influenced by the type of 
SNEDDS component (Dahan and Hoffman, 2008) . In 
general, lipid-based delivery system should maximize 
the rate and amount of drug is dissolved in the intestinal 
lumen and maintain the drug in solution during transit in 
the gastrointestinal tract in order to obtain an increase 
in absorption on oral administration. Therefore, it is 
necessary to evaluate the solubilization of drug 
administered using a lipid delivery system (Dahan and 
Hoffman, 2008). An in vitro model using a medium that 
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simulates the digestive juices can be utilized to predict 
the effect of dilution and digestion of lipid-based 
formulations in digestive fluids (Fatouros and Mullertz, 
2008).  
Based on those backgrounds, this study was 
aimed to obtain optimum formula of SNEDDS -
pterostilbene using soybean oil and a combination of 
surfactant and co-surfactant and evaluate the 
effectiveness of the formula in increasing 
bioaccessibility of pterostilbene using in vitro digestion 
model.  
 
2. Materials and Methods 
\ 
Pterostilbene ≥97% pro HPLC (Sigma-Aldrich 
Singapore) dan pterostilbene food grade (Pteropure®, 
Chromadex USA). Soybean oil as lipid phase (Indofood 
Happy Salad® soya oil). Croduret® 50, Tween 80, Span 80 
(Croda, Singapore) and polyethylene glycol 400 
(Petronas Chemical Derivatives, Malaysia) as surfactants 
and co-surfactants. Pancreatic lipase  and bile extract 
(Sigma-Aldrich Singapore). All other chemicals and 
solvents were of analytical grade. 
 
2.2. Solubility test  
Determination of pterostilbene solubility in 
soybean oil was determined using shake flask method. 
An excess amount of pterostilbene was added to 1 mL 
of soybean oil. The mixture was shaken at 100 rpm for 
24 hours at room temperature in incubator shaker, 
followed by equilibrium for 24 hours at room 
temperature. The mixture was then centrifuged at 3000 
rpm for 10 min in a microcentrifuge Thermo Sorvall 
LM17. Aliquot of supernatant was filtered through 0.4 5 
µm membrane filter. The filtered sample was then 
diluted with ethanol  and the amount of pterostilbene 
solubilized was analysed using validated spectro -
photometer method at 320 nm (Shimadzu UV-1700). 
 
2.3. Determination of surfactant and co-surfactant  
Preliminary screening was carried out to select 
proper type and combination of surfactant and co -
surfactant based on its ability in forming clear dispersion 
in water when combined with soybean oil. Various 
combination of surfactant and co-surfactant in each 
mixture was calculated based on Hydrophile Lipophile 
Balance (HLB) at 12 and 14 (Table 1) (Hauss et al., 1998). 
The surfactant and co-surfactant mixture (Smix) then 
combined with soybean oil in various weight ratios at 
90:10; 85:15; 80:20; 75:25; 70:30; 68:32; 65:35; and 60:40, 
respectively. The mixture was prepared by stirring at 
400 rpm at 40 oC. The efficiency of nanoemulsion 
formation was assessed by adding 100 µL of the mixture 
to 5 mL of water and slowly shaken. Combination of the 
Smix and soybean oil was judged as capable in forming 
SNEDDS if only the dispersion resulted in water was 
clear or slight bluish. This preliminary study obtained 
low and high concentration range of surfactant, co -
surfactant, and soybean oil which was used as basis in 
formulation optimization.   
 
2.4. Optimization of SNEDSS-pterostilbene formula 
D-optimum mixture design using Design-Expert 
(trial version 9.0.6.2) was used to optimize the 
composition of SNEDDS. The mixture experimental 
study was designed based on a three component 
system: the oil phase A (soybean oil), the surfactant B 
(Croduret® 50), and co-surfactant C (Span 80). The total 
concentration of the three components summed to 
100%. The PEG 400 and pterostilbene contents were 
kept constant at 40% and 50 mg of the prepared 
SNEDDS (Table 2). Based on the preliminary study of 
surfactant and co-surfactant determination the range of 
each component was selected as follows: soybean oil 
(10-32%), Croduret® 50 (53.45-70.74%), and Span 80 
(14.55-19.26%).  The emulsification time (Y1) and 
transmittance of diluted SNEDDS (Y2) were used as 
response in judging optimum formula. The optimum 
formulation of this study was selected to have 
emulsification time less than 1 min and transmittance of 
diluted SNEDDS more than 80%.  
 
2.5. Characterizat ion of optimum SNEDDS -
pterostilbene formula 
2.5.1. Determination of emulsification time  
Emulsification time is the time needed to reach 
the emulsified and homogeneous mixture upon dilution 
(Basalious et al., 2010) and slow agitation. 1 gram of 
each SNEDDS-pterostilbene was added to 200 mL of 
HCL 0.1 N 37 0C with agitation at 100 rpm. Emulsification 
time was recorded from the first time the SNEDDS-
pterostilbene added into the media.  
 
2.5.2. Spectroscopic characterization of optical clarity  
The optical clarity was judged by % transmittance. 
100 µL of optimum formula was diluted with 5 mL of 
water and gently shaken. The absorbance of each 
formulation was measured at 650 nm using water as a 
blank. 
 
2.5.3. Droplet size measurement 
100 µL was diluted with 5 mL of water and gently 
shaken. The droplet size of the resulted dispersion was 
determined by dynamic light scattering method (Horiba 
Scientific). Light scattering was monitored at 25 0C and 
at a 900 angle. 
 
2.6. In vitro digestion of SNEDDS-pterostilbene  
Optimum formula of SNEDDS-pterostilbene was 
passed through a two-step in vitro digestion model that 
simulated gastric and small intestine digestion. 
Simulated gastric fluid (SGF) was prepared by dissolving 
2 gram NaCl and 7 mL HCl 37% in water (total 1 L 
volume), then the pH was adjusted to 1.2. The simulated 
small intestinal fluid (SSIF) contained 2.5 mL pancreatic 
lipase solution (60 mg, PBS, pH 7.0), 3.5 mL bile extract 
solution (187.5 mg, PBS, pH 7.0, 37 °C) and 1.5 mL salt 
solution (0.5 M CaCl2 and 5.6 M NaCl in water) which 
was each of those solution were prepared separately 
and added in sequential at small intestine phase (Qian et 
al., 2012; Sun et al., 2015). 
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2.6.1. Gastric phase 
One gram of SNEDDS -pterostilbene was 
dispersed into 20 mL of  SGF and pH was adjusted to 2,5 
and then incubated for 2 h in incubator shaker at 37 °C 
and 100 rpm.  
 
2.6.2. Small intestine phase  
The pH sample obtained from the gastric phase 
was then adjusted to 7.0. While kept on stirring, 3.5 mL 
of bile extract solution and 1.5 mL each of CaCl2 0,5 M 
and NaCl 5.6 M were added into the sample. The 
resulting mixture was re-adjusted to pH 7.0 and then 2.5 
mL pancreatic lipase solution was added. The mixture 
then titrated using NaOH 0.1 N to maintain pH at 7.0 for 
2 h.  
 
2.6.3. Determination of bioaccessibility  
Sample obtained from in vitro digestion was 
termed as raw digesta, then collected and centrifuged 
3000 rpm for 40 min. The middle  phase was assumed to 
contain of mixed micelles that solubilized pterostilbene 
(Rao et al., 2013). Aliquot of the middle phase was 
collected and prepared for spectrophotometer analysis. 
Pterostilbene that solubilized in the middle phase was 
calculated as bioaccessibility using the following 
equation (1) (Qian et al., 2012).  
% bioaccessibility  =  …… (1) 
Cmicelle is concentration of pterostilbene in the 
middle phase and Cemulsion is concentration of 
pterostilbene in SNEDDS. 
 
3. Results and Discussion 
3.1. Solubility test  
Obtained solubility of pterostilbene in soybean oil  
was 72.76 ± 1.82 mg/mL. This re sult indicate that 
soybean oil has sufficient capacity in dissolving 
pterostilbene considering the dosage of administration 
is 50 mg (Riche, 201 3). Pterostilbene solubility in 
soybean oil is important therefore to ensure when 
SNEDDS-pterostilben is dispersed in aqueous medium 
will remain in state of dissolved in emulsion droplet and 
form a clear dispersion (Kommuru et al., 2001). 
Maintaining pterostilbene, as well as other drugs that 
formulated in SNEDDS, remained stable in a state 
dissolved when dispersed in an aqueous medium is 
important therefore to reduce the possibility of 
pterostilbene precipitation when it is in the digestive 
fluids (Pouton and Porter, 2008). 
 
3.2. Determination of surfactant and co-surfactant  
In this study, combination surfactant an d co-
surfactant that were able in forming SNEDDS system 
using soybean oil were combination of high and low 
HLB. Based on the screening the high HLB of surfactant 
that used in this study was Croduret® 50 (HLB 14.1) and 
low HLB of co-surfactant was Span 80 ( HLB 4.3). The 
combination of the two surfactants was made in certain 
percentage in order to obtain total HLB of 12. According 
to Pouton (2000) surfactant that can be used in 
formulating self-emulsifying system usually which has 
HLB of not less than 11. Agubata et al. (2014) and Cuiné 
et al. (2008) explained that the most recommended 
surfactants for SNEDDS were non-ionic hydrophilic with 
HLB of more than 12. To develop formulations that  are 
self-emulsified require an appropriate mix between a 
low HLB surfactant and a high HLB in order the formed 
nano-emulsion is table  (Pouton, 2000). Müllertz et al . 
(2010) and Pouton (2000) explained that incorporating 
more hydrophilic surfactant and co-surfactant or co-
solvents to lipid and surfactant mixture effectively 
reduces the oil-water interfacial tension resulting 
emulsion droplet size of the nanoscale spontaneously 
with mild stirring.  
  
3.3. Optimization of  SNEDSS-pterostilbene 
formulation 
As shown in Table 2, the response of 
emulsification time for each formulations were less than 
1 min and the transmittance were more than 90%. Those 
responses then analysed to determine the fitted model 
in describing each variable effect on each response.  The 
summary results of the analysis suing Design-Expert 
(trial version 9.0.6.2) is shown in Table 3.  
Table 3 shows that the most fitted model in 
describing effects of various combination of variable A 
(soybean oil), B (Croduret® 50), and Span 80 (C) on 
response of emulsification time is linear, while on 
response of transmittance is quadratic. Then to ensure if 
the model is significant or just random noise  in the data, 
it is necessary to note the results of ANOVA analysis, 
which are the value of Prob> F for the model has to be 
significant (<0.0500) and the value of Prob> F for lack o f 
fit should not be significant (> 0.0500). Summary results 
of ANOVA analysis of mathematical model for the 
response of emulsification time and transmittance is 
shown in Table 4.  
Table 4 shows that the Prob>F value of each 
model for variable A, B, and C in describing its effects on 
emulsification time and transmittance are significance 
and the Prob> F value of lack of fit for each models are 
not significance. The coefficient of variable A, B and C 
form the equation (2) and (3) follows:  
Ywaktu emulsifikasi  = –0.27428A + 0.46865B + 1.19674C… (2)  
Y% transmitan = –0.14224A+1.21846B+4.13106C+0.010177 AB  
– 0.00405 AC – 0.056047 BC …(3)  
A positive sign on the coefficients indicate a 
synergistic effect while a negative sign indicates the 
antagonistic effect on the response (Huang et al., 2004). 
The bigger the coefficient means that the variable has a 
strong influence on the response (Basalious et al., 2010).  
The desired optimum formula of this study is a 
formula that has a minimum emulsification time and 
maximum transmittance. Both criteria of optimum 
SNEDDS formula were then combined to determine the 
scope of the optimum combination of the variables with 
the provisions of the concentration of each variable was  
maximum for soybean oil and minimum for Corduret® 
50 and Span 80. Results of Design-Expert analysis that 
combines the two criteria of desired optimum formula 
(Fig. 1) shows that the composition of 27.29% soybean 
oil; Croduret  50® of 53.45%;  and  Span 80 of 19.26%  was  
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predicted as the most optimum formula in resulting 
optimum response. Thus, the formula was selected as 
optimum formula. This formula was then verified by 
experimental preparation and evaluated its 
emulsification time and transmittance. Observed data 
obtained from this evaluation was then compared to the 
predicted value of each response (Table 5).  
Result of one-Sample T-Test analysis using MS 
Excel 2010 does not show significance difference 
between predicted values of emulsification time as well 
as transmittance to observed value of those response. 
P-value for emulsification time and transmittance are 
0.26 and 0.41 (>0,05), respectively. This means that the 
hypothesis of no difference between the observations 
and the prediction value of each response is confirmed. 
Thus the mathematical model obtained in this study is 
valid (Basalious et al., 2010). 
  
Table 1. Surfactant mixture (Smix) in total HLB of 12 and 14  
 
   
Smix HLB Composition % w/w 
 Span 80 Tween 80 
1 12 28.0 72.0 
2 14 9.3 90.7 
 Croduret® 50 Span 80 
3 12 78.6 21.0 
4 14 99.0 1.0 
 
Table 2. The formulation of mixture design and their response results  
 
F 
Soybean oil Croduret® 50 Span 80 Total A+B+C 
% w/w 
PEG 400  
% w/w 
Total 
SNEDDS 
Pterostilbene 
% w/w 
Y1 
ET 
Y2 
%T A B C 
1 21.0 62.0 16.9 100 40 140 5 43,62 95,374 
2 21.0 62.0 16.9 100 40 140 5 45,12 95,105 
3 12.3 70.7 16.9 100 40 140 5 46,69 94,922 
4 10.0 70.7 19.2 100 40 140 5 50,33 94,678 
5 29.6 53.4 16.9 100 40 140 5 31,91 94,128 
6 15.8 64.9 19.2 100 40 140 5 46,63 96,155 
7 21.0 62.0 16.9 100 40 140 5 44,99 95,996 
8 24.1 57.7 18.0 100 40 140 5 35,28 95,178 
9 14.7 70.7 14.5 100 40 140 5 48,11 96,338 
10 17.9 66.4 15.7 100 40 140 5 51,80 95,740 
11 32.0 53.4 14.5 100 40 140 5 34,16 91,980 
12 27.3 53.4 19.2 100 40 140 5 45,10 95,703 
13 15.8 64.9 19.2 100 40 140 5 53,70 94,910 
14 26.2 59.2 14.5 100 40 140 5 33,97 94,885 
15 29.6 53.4 16.9 100 40 140 5 42,85 94,958 
16 32.0 53.4 14.5 100 40 140 5 32,18 92,725 
 
Table 3. Summary results of equation models analysis 
 
Model Y1 (emulsif ication time)  Y2 (% transmittance)  
Linear SD 4,34 0,99 
 R2 0,6822 0,3724 
 Adjusted-R2 0,6333 0,2759 
 Pred. R-Square 0,5235 -0,1132 
 PRESS 367,41* 22,75 
Quadratic  SD 4,69 0,52 
 R2 0,7145 0,8673 
 Adjusted-R2 0,5718 0,8010 
 Pred. R-Square 0,3737 0,6730 
 PRESS 482,92 6,68*  
Special Cubic  SD 4,93 051  
 R2 0,7161  0,8863 
 Adjusted-R2 0,5268 0,8105 
 Pred. R-Square 0,1192 0,6347 
 PRESS 679,13 7,47 
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3.4. Characterizat ion of prepared optimum 
SNEDDS-pterostilbene  
The results of measurements of droplet size of 
dispersed optimum formula using dynamic light 
scattering method was 31.8 nm with a polydispersity 
index (PI) was 0.229 and had zeta potential of -42.5 mV.  
 
3.5. In vitro digestion model 
An in vitro model using medium that simulates 
the digestive juices can be used to predict the effect of 
dilution and digestion of lipid-based formulations in 
digestive fluids (Fatouros and Mullertz, 2008). 
Bioaccessibility of pterostilbene obtained from optimum 
formula of SNEDSS was 91.48±2.28% while from sample 
that was not formulated into SNEDDS was 4.63±1.11%. 
Reason for low pterostilbene bioaccessibility that was 
not formulated in SNEDDS was due to low solubility in 
aqueous solutions and lack of mixed micelle that 
solubilize the pterostilbene. It is considering that the 
mixed micelle is the result of digestion of lipid 
components contained in SNEDDS by digestive enzyme. 
It means no lipid, then no mixed micelle is formed. 
During the in vitro experiment, the pterostilben that 
was not formulated into SNEDDS was precipitated. It is 
an indication that pterostilbene will precipitate in 
gastrointestinal tract whenever it is not formulated into 
SNEDDS. This will lead to low amount of pterostilbene 
that ready to be absorbed. The more mixed micelle is 
formed the more pterostilbene that solubilized (Yang 
and McClements, 201 3). Thus, the more lipid component 
used in SNEDDS the more increased the amount of 
pterostilbene that ready to be absorbed and is higher 
bioavailability. 
 
4. Conclusions  
Optimum formula of SNEDDS-pterostilben was 
obtained by the combination of non-ionic surfactant 
with HLB >12, that was  Croduret® 50 which has HLB of 
14,1 and Span 80 which has lower HLB, that was 4,3. The 
ratio of components of the optimum formula was 
soybean oil: Croduret® 50:Span 80: PEG 400 (16,37 %, 
32,07 %, 11,56 %, and 40 %). The oil component of the 
SNEDDS was able in improving pterostilbene 
bioaccessibility compared to pterostilbene that was not 
formulated into SNEDDS, assessed by simulated 
gastrointestinal liquid.  
Tabel 4. Summary results of ANOVA analysis of mathematical models 
 
Response  Source  Sum of Squares Mean Square  F Value  Prob > F 
Emulsificat ion 
time 
Model 525,97 262,98 13,95 0,0006*  
Linear Mixture 525,97 262,98 13,95 0,0006 
Residual  245,06 18,85   
Lack of Fit  156,89 19,61 11 0,4749* 
% 
Transmittance 
Model 17.72 3.54 13.07 0.0004*  
Linear Mixture 7.61  3.81  14.03 0.0013 
AB 1.69 1.69 6.22 0.031 8 
AC 1.604E-003 1.604E-003 5.916E-003 0.9402 
BC 0.27 0.27 1.00 0.3403 
Residual  2.71 0.27   
Lack of Fit  0.90 0.18 0.49 0.7710*  
 
 
 
 
Figure 1. Overlay of variables effect on emulsification time and transmittance  
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